Thein vivo andin vitro effects of interleukin-1 and tumor necrosis factor on murine cytomegalovirus infection
- 1 September 1989
- journal article
- research article
- Published by Springer Nature in Biotherapy
- Vol. 1 (3) , 227-231
- https://doi.org/10.1007/bf02170891
Abstract
The effects of tumor necrosis factor (TNF) and interleukin-1 (IL-1) on infection with murine cytomegalovirus (MCMV) were investigatedin vitro andin vivo. The addition of each of these cytokines (at 1 ng/ml) to tissue culture monolayers 24 hr prior to MCMV challenge produced a reproducible decrease in vital titer (from 1 × 108 pfu to approximately 4 × 106 pfu for both cytokines). There was no further increase in this effect when a 10 or 100 ng/ml of each of these cytokines was employed. Despite thesein vitro effects, the pretreatment of suckling, weanling, or adult mice with 80 or 400 ng of TNF or IL-1 alone, or 80 ng of each cytokine together, had no effect on the survival of mice following MCMV. Similarly, neither of these cytokines adversely influenced the protective effects of hyperimmune anti-MCMV antiserum; that is, they did not attenuate the protection conferred by the antiserum nor affect the protective effects of subtherapeutic doses of the antiserum. We conclude that despite promising antiviral effects against MCMVin vitro, these agents do not result in a useful therapeutic effectin vivo. Moreover, despite the ability of IL-1 to induce ACTH and corticosterone in mice, IL-1 treatment did not increase the mortality to CMV.Keywords
This publication has 11 references indexed in Scilit:
- The effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infectionBiotherapy, 1989
- Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1European Journal of Immunology, 1988
- Influence of Interferons 11 and and of Tumour Necrosis Factor on Persistent Infection with Bovine Viral Diarrhoea Virus in VitroJournal of General Virology, 1988
- A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection.Proceedings of the National Academy of Sciences, 1988
- Clinical Approach to Infection in the Compromised HostPublished by Springer Nature ,1988
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- The Antiviral Activity of Recombinant Human Tumor Necrosis Factor-αJournal of Interferon Research, 1987
- Tumour necrosis factors α and β inhibit virus replication and synergize with interferonsNature, 1986
- Antiviral effects of recombinant tumour necrosis factor in vitroNature, 1986
- PRIMARY CYTOMEGALOVIRUS INFECTION FOLLOWING CARDIAC TRANSPLANTATION IN A MURINE MODELTransplantation, 1984